Platelet-derived endothelial cell growth factor as a prognostic factor for radiotherapy outcome in patients with adenocarcinoma of the uterine cervix

By Ryu S.-Y.   Oka K.   Tsujii H.   Suzuki Y.   Nakano T.  

Gynecologic Oncology, Vol. 89, Iss. 3, 2003-06 ,pp. : 414-419

Elsevier

Access to resources Recommend Favorite

Expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human gallbladder lesions

By Yamamoto S.   Kitadai Y.   Tsuchida A.   Sasaki T.   Matsubara K.   Kajiyama G.  

European Journal of Cancer, Vol. 36, Iss. 2, 2000-01 ,pp. : 257-263

Elsevier

Access to resources Recommend Favorite

Effects of hesperetin on platelet-derived growth factor-BB-induced pulmonary artery smooth muscle cell proliferation

By                

Molecular Medicine Reports, Vol. 13, Iss. 1, 2016-01 ,pp. : 955-960

Spandidos Publications

Access to resources Recommend Favorite

Thymidine Phosphorylase (Platelet-Derived Endothelial Cell Growth Factor) as a Target for Capecitabine: From Biology to the Bedside

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 1, Iss. 2, 2006-06 ,pp. : 171-183

Bentham Science Publishers

Access to resources Recommend Favorite

Platelet-derived growth factor may be a potential diagnostic and prognostic marker for cholangiocarcinoma

By Boonjaraspinyo Sirintip  

Tumor Biology, Vol. 33, Iss. 5, 2012-10 ,pp. : 1785-1802

Springer Publishing Company

Access to resources Recommend Favorite